Pasithea Therapeutics Corp.
(NASDAQ: KTTA)
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
1.190
+0.030
(+2.59%)
Range
1.120 - 1.210
(8.04%)
Open
1.140
Previous Close
1.160
Bid Price
0.355
Bid Volume
13
Ask Price
0.369
Ask Volume
10
Volume
655,681
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 01:07.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
